Exploring the targeting spectrum of rocaglates among eIF4A homologs
RNA · 2023
DOI: 10.1261/rna.079318.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2023. Verfasst von Sai Kiran Naineni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, McGill University, Quebec, H3G 1Y6 Canada. Hauptthemen laut MEDLINE: RNA, Nonsense Mediated mRNA Decay. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Inhibition of eukaryotic translation initiation through unscheduled RNA clamping of the DEAD-box (DDX) RNA helicases eIF4A1 and eIF4A2 has been documented for pateamine A (PatA) and rocaglates—two structurally different classes of compounds that share overlapping binding sites on eIF4A. Clamping of eIF4A to RNA causes steric blocks that interfere with ribosome binding and scanning, rationalizing the potency of these molecules since not all eIF4A molecules need to be engaged to elicit a biological effect. In addition to targeting translation, PatA and analogs have also been shown to target the eIF4A homolog, eIF4A3—a helicase necessary for exon junction complex (EJC) formation. EJCs are deposited on mRNAs upstream of exon-exon junctions and, when present downstream from premature termination codons (PTCs), participate in nonsense-mediated decay (NMD), a quality control mechanism aimed at preventing the production of dominant-negative or gain-of-function polypeptides from faulty mRNA transcripts. We find that rocaglates can also interact with eIF4A3 to induce RNA clamping. Rocaglates also inhibit EJC-dependent NMD in mammalian cells, but this does not appear to be due to induced eIF4A3-RNA clamping, but rather a secondary consequence of translation inhibition incurred by clamping eIF4A1 and eIF4A2 to mRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, McGill University, Quebec, H3G 1Y6 Canada.
- Department of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Massachusetts 02215, USA.
- Centre de Recherche en Biologie Structurale (CRBS), McGill University, Quebec, H3G 0B1 Canada.
- Department of Biochemistry, McGill University, Quebec, H3G 1Y6 Canada jerry.pelletier@mccgill.ca.
- McGill Research Center on Complex Traits, McGill University, Quebec, H3G 0B1 Canada.
- Rosalind and Morris Goodman Cancer Research Centre, McGill University, Quebec, H3A 1A3 Canada.
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
- Canadian Institutes of Health Research
- National Institutes of Health
Zitieren
APA
Naineni, S. K., Cencic, R., Robert, F., Brown, L. E., Haque, M., Scott-Talib, J., Sénéchal, P., Schmeing, T. M., Porco, J. A., & Pelletier, J. (2023). Exploring the targeting spectrum of rocaglates among eIF4A homologs. RNA. https://doi.org/10.1261/rna.079318.122
Vancouver
Naineni SK, Cencic R, Robert F, Brown LE, Haque M, Scott-Talib J, et al. Exploring the targeting spectrum of rocaglates among eIF4A homologs. RNA. 2023. doi:10.1261/rna.079318.122
BibTeX
@article{Naineni2023,
author = {Naineni, Sai Kiran and Cencic, Regina and Robert, Francis and Brown, Lauren E and Haque, Minza and Scott-Talib, Jordan and Sénéchal, Patrick and Schmeing, T Martin and Porco, John A and Pelletier, Jerry},
title = {Exploring the targeting spectrum of rocaglates among eIF4A homologs},
journal = {RNA},
year = {2023},
doi = {10.1261/rna.079318.122}
}
EUVIMED